「the 20」の検索結果
145件：51～55件目を表示
-
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
o-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日 開催地：Athens, GREE...
https://www.senju.co.jp/rd/society/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
zed, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology, Toho University Faculty of...
https://www.senju.co.jp/rd/thesis/ -
Company Profile | About Senju | SENJU Pharmaceutical
6-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi Sugisawa Managin...
http://www.senju.co.jp/english/about/outline.html -
Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for ImageFS” in Japan. MIEr for ImageFS can sharpen ...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf -
Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for ImageFS” in Japan. MIEr for ImageFS can sharpen ...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126_0.pdf